{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreig4hswoqcgbe3lce3mkwe27dhrnf3pdcrhi6zpuvlmd27ni7wr2m4",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mel3rnz7cll2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihjeyep2d23cb62ndnq6swjln57r4bgvkweveq6b5uj6ttstwbtla"
    },
    "mimeType": "image/jpeg",
    "size": 40371
  },
  "path": "/2026/02/10/trumprx-hype-or-real-savings-novo-nordisk-hims-compounding/?utm_campaign=rss",
  "publishedAt": "2026-02-10T15:45:41.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Business",
    "D.C. Diagnosis",
    "Insurance",
    "Pharma",
    "Politics",
    "Congress",
    "Drug prices",
    "Health insurance",
    "Pharmaceuticals",
    "Policy",
    "STAT+"
  ],
  "textContent": "This is the web edition of STAT's D.C. Diagnosis newsletter.",
  "title": "STAT+: TrumpRx: Hype or real savings?",
  "updatedAt": "2026-02-10T15:45:45.000Z"
}